These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 34074270)

  • 1. Changing trends in liver transplantation indications in Saudi Arabia: from hepatitis C virus infection to nonalcoholic fatty liver disease.
    Alqahtani SA; Broering DC; Alghamdi SA; Bzeizi KI; Alhusseini N; Alabbad SI; Albenmousa A; Alfaris N; Abaalkhail F; Al-Hamoudi WK
    BMC Gastroenterol; 2021 Jun; 21(1):245. PubMed ID: 34074270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances.
    Noureddin M; Vipani A; Bresee C; Todo T; Kim IK; Alkhouri N; Setiawan VW; Tran T; Ayoub WS; Lu SC; Klein AS; Sundaram V; Nissen NN
    Am J Gastroenterol; 2018 Nov; 113(11):1649-1659. PubMed ID: 29880964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
    Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
    World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of DAAs on liver transplantation: Major effects on the evolution of indications and results. An ELITA study based on the ELTR registry.
    Belli LS; Perricone G; Adam R; Cortesi PA; Strazzabosco M; Facchetti R; Karam V; Salizzoni M; Andujar RL; Fondevila C; De Simone P; Morelli C; Fabregat-Prous J; Samuel D; Agarwaal K; Moreno Gonzales E; Charco R; Zieniewicz K; De Carlis L; Duvoux C;
    J Hepatol; 2018 Oct; 69(4):810-817. PubMed ID: 29940268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.
    Goldberg D; Ditah IC; Saeian K; Lalehzari M; Aronsohn A; Gorospe EC; Charlton M
    Gastroenterology; 2017 Apr; 152(5):1090-1099.e1. PubMed ID: 28088461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic Steatohepatitis Becomes the Leading Indication for Liver Transplant Registrants Among US Adults Born Between 1945 and 1965.
    Shirazi F; Wang J; Wong RJ
    J Clin Exp Hepatol; 2020; 10(1):30-36. PubMed ID: 32025164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C remains leading indication for listings and receipt of liver transplantation for hepatocellular carcinoma.
    Singal AK; Satapathy SK; Reau N; Wong R; Kuo YF
    Dig Liver Dis; 2020 Jan; 52(1):98-101. PubMed ID: 31582326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of liver transplantation for nonalcoholic steatohepatitis-associated hepatocellular carcinoma.
    Holzner ML; Florman S; Schwartz ME; Tabrizian P
    HPB (Oxford); 2022 Apr; 24(4):470-477. PubMed ID: 34544629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Future Trends in Demand for Liver Transplant: Birth Cohort Effects Among Patients With NASH and HCC.
    Shingina A; DeWitt PE; Dodge JL; Biggins SW; Gralla J; Sprague D; Bambha K
    Transplantation; 2019 Jan; 103(1):140-148. PubMed ID: 30451739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes.
    Cholankeril G; Wong RJ; Hu M; Perumpail RB; Yoo ER; Puri P; Younossi ZM; Harrison SA; Ahmed A
    Dig Dis Sci; 2017 Oct; 62(10):2915-2922. PubMed ID: 28744836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of direct anti-HCV drugs improves early post-liver transplant survival and induces significant changes in waiting list composition.
    Crespo G; Trota N; Londoño MC; Mauro E; Baliellas C; Castells L; Castellote J; Tort J; Forns X; Navasa M
    J Hepatol; 2018 Jul; 69(1):11-17. PubMed ID: 29481821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma.
    Young K; Aguilar M; Gish R; Younossi Z; Saab S; Bhuket T; Liu B; Ahmed A; Wong RJ
    Liver Transpl; 2016 Oct; 22(10):1356-66. PubMed ID: 27348270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in liver transplantation for hepatitis C in a country with reduced access to direct-acting antiviral agents.
    Dirchwolf M; Marciano S; Giunta DH; Posadas-Martínez ML; Biggins SW; Ruf AE
    Clin Transplant; 2018 Apr; 32(4):e13230. PubMed ID: 29485711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High incidence of hepatocellular carcinoma and postoperative complications in patients with nonalcoholic steatohepatitis as a primary indication for deceased liver transplantation.
    Kern B; Feurstein B; Fritz J; Fabritius C; Sucher R; Graziadei I; Bale R; Tilg H; Zoller H; Newsome P; Eschertzhuber S; Margreiter R; Öfner D; Schneeberger S
    Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):205-210. PubMed ID: 30320609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapy.
    Flemming JA; Kim WR; Brosgart CL; Terrault NA
    Hepatology; 2017 Mar; 65(3):804-812. PubMed ID: 28012259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study.
    Ferrarese A; Germani G; Gambato M; Russo FP; Senzolo M; Zanetto A; Shalaby S; Cillo U; Zanus G; Angeli P; Burra P
    World J Gastroenterol; 2018 Oct; 24(38):4403-4411. PubMed ID: 30344424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in the United States.
    Younossi ZM; Stepanova M; Ong J; Trimble G; AlQahtani S; Younossi I; Ahmed A; Racila A; Henry L
    Clin Gastroenterol Hepatol; 2021 Mar; 19(3):580-589.e5. PubMed ID: 32531342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Changing Etiologic Scenario in Liver Transplantation: A Single-Center Cohort Study From Turkey.
    Serin A; Sahin T; Arikan BT; Emek E; Bozkurt B; Tokat Y
    Transplant Proc; 2019 Sep; 51(7):2416-2419. PubMed ID: 31402253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic Steatohepatitis: A Rapidly Increasing Indication for Liver Transplantation in India.
    Jothimani D; Danielraj S; Narasimhan G; Kaliamoorthy I; Rajakumar A; Palaniappan K; Palanichamy S; Rammohan A; Ramachandran H; Rajalingam R; Rela M
    J Clin Exp Hepatol; 2022; 12(3):908-916. PubMed ID: 35677507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreasing frequency and improved outcomes of hepatitis C-related liver transplantation in the era of direct-acting antivirals - a retrospective cohort study.
    Arora SS; Axley P; Ahmed Z; Satapathy SK; Wong R; Kuo YF; Singal AK
    Transpl Int; 2019 Aug; 32(8):854-864. PubMed ID: 30866110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.